Stock Analysis·← Pickers

KNW

Know Labs, Inc.

Know Labs, Inc. (KNW) is currently in a range/mixed trend, trading below both the 50-day and 200-day moving averages. RSI is at 31.6, with 1/3 trend checks passing.

Price
$2.14
2026-07-16
Trend score
1/3
Range / Mixed
RSI (14)
31.6
Neutral
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

KNW with MA50 and MA200

4.433.342.241.150.0507/1210/0701/0206/1609/11
KNW2024-07-122025-09-11
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$2.01-60.08% vs price
MA200
$0.97-17.07% vs price
RSI (14)
31.6Neutral zone
MACD Signal
MixedMACD near signal line
Macro Support
Not identifiedNo repeated weekly support zone found
Support Quality
Volume data unavailable
Chart Summary
Trend summary for KNW

Know Labs, Inc. (KNW) currently looks more uncertain than directional, with a fairly mixed technical picture. The latest available price is $2.14, and 1 of 3 core trend checks are currently passing. Price is trading below the 50-day moving average by 60.1% and below the 200-day moving average by 17.1%.

Momentum and stretch context

KNW currently has an RSI reading of 31.6, which leans a little softer than neutral. That does not automatically make the chart bearish, but it does suggest momentum is not especially strong right now.

What traders may watch next

This page is designed to help you quickly understand what the KNW chart looks like before opening the full dashboard. The aim is not to tell you what to buy or sell, but to make it easier to judge whether the stock is trending cleanly, becoming stretched, or simply moving in a more awkward range.

Company profile

About Know Labs, Inc.

Know Labs, Inc., an American enterprise, is dedicated to the creation and market introduction of its proprietary technologies. At the heart of its operations is a technology known as Bio-RFID, which employs spectroscopy to transmit electromagnetic energy through substances or materials, thereby identifying and capturing their unique molecular signatures. This Bio-RFID system boasts adaptability, allowing for its incorporation into diverse form factors such as wearable devices, mobile applications, and stationary laboratory equipment. Its initial commercial offering leveraging Bio-RFID is a glucose monitoring product designed to furnish users with instantaneous data regarding their blood glucose concentrations. The company, initially named Visualant, Incorporated, officially adopted the name Know Labs, Inc. in May 2018. Established in 1998, Know Labs, Inc. operates from its headquarters in Seattle, Washington.

Sector
Technology
Industry
Hardware, Equipment & Parts
CEO
Ronald P. Erickson
Employees
12
Market cap
$16.1M
Beta
1.76
52-week range
$0.33 – $14.80
Dividend
No
Exchange
AMEX
Country
US
IPO date
18 Apr 2006
ISIN
US4992382022
CUSIP
499238202
Company profile data from Financial Modeling Prep. KNW listed on AMEX.
Share dilution

KNW shares outstanding over time

Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.

Mar 2019Mar 2026
Shares outstanding (latest)
388.1M
Since Mar 2019
+2045.2%
Trend
More shares outstanding
Historical shares-outstanding data from Financial Modeling Prep. KNW28 data points from Mar 2019 to Mar 2026.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about KNW

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.